Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Advanced Oncotherapy (AVO)

Intraday
Historical

Price	1.925p on 28-11-2023 at 06:00:04
Change	0.00p 0%
Buy	0.00p
Sell	0.00p
Buy / Sell AVO Shares

Last Trade:	-
Day's Volume:	0
Last Close:	1.925p
Open:	0.00p
ISIN:	GB00BD6SX109

Day's Range	0.00p - 0.00p
52wk Range:	1.875p - 17.25p
Market Capitalisation:	£10m
VWAP:	0.00p
Shares in Issue:	543m

Sector: Medical Services

Listed In: FTSE AIM All-Share,

Buy/Sell	Volume	Trade Prc	Trade Type	Trade Time
Recent Trades History Advanced Oncotherapy (AVO)

Share Price History for Advanced Oncotherapy
Time period: to
Date	Open	High	Low	Close	Volume

Share News for Advanced Oncotherapy

IN BRIEF: Advanced Oncotherapy in talks over possible cash injection

23rd Oct 2023 18:51

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Updates on financing discussions and current financial position. Signs non-binding term sheet with a third-party investor. Investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing. Read More

IN BRIEF: Advanced Oncotherapy results delayed, funding talks continue

3rd Oct 2023 18:29

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - On Friday, says it is not in a position to publish its accounts for the year ended December 31, 2022, and the unaudited interim results for the six months ended June 30, together with the 2022 annual report. Explains the 2023 interim results are contingent on the finalisation and publication of the 2022 annual report. Read More

Advanced Oncotherapy plans to raise up to GBP110 million

17th Jul 2023 21:41

(Alliance News) - Advanced Oncotherapy PLC on Monday announced a prospective recapitalisation and funding plan to raise up to GBP110 million. Read More

TRADING UPDATES: Jadestone Energy holds production and capex targets

30th Jun 2023 19:54

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Friday and not separately reported by Alliance News: Read More

IN BRIEF: Advanced Oncotherapy optimistic of securing further funding

2nd Jun 2023 19:37

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment company - Announces it has received a conversion notice for a portion of the convertible notes, which were issued to a French counterparty, as announced March 1 into new shares in the company. Says 10 convertible notes have been converted worth GBP50,000 at a conversion price of GBP0.25. Company also pays GBP56,702 conversion fee as the conversion price is below the nominal value of the shares. States this will be settled through the issuance of 756,020 new shares. Further, says in talks to raise further funding under the secured loan note agreement as well as through other non-dilutive financing options and is hopeful of securing additional financing during June 2023. Optimistic of a satisfactory outcome on the financing options being explored. In addition, company says it has issued convertible notes totalling GBP34,600 under its secured convertible loan note agreement. Read More

FTSE 100 Latest

Value7,428.14

Change-32.56